Dr. Bhave is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6100 W 96th St
Ste 125
Indianapolis, IN 46278Phone+1 317-715-1803Fax+1 317-715-6200
Summary
- I am a board certified radiation oncologist and partner at Cancer Care Group(CCG). CCG is a radiation oncology group practice in central Indiana. I mainly practice at Franciscan Health Indianapolis and Mooresville but I also have credentialing at several hospitals in the central Indiana area.
Education & Training
University of ChicagoM.S., Public Health Sciences for Clinical Health Professionals, 2017 - 2019
University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 2015 - 2019
Ascension Illinois/Saint FrancisInternship, Transitional Year, 2014 - 2015
Washington University in St. Louis School of MedicineClass of 2014, MD
Duke UniversityB.S., Biology and Psychology, 2005 - 2009
Certifications & Licensure
IN State Medical License 2019 - 2025
IL State Medical License 2014 - 2019- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2024
- Rising Star Castle Connolly, 2023
Publications & Presentations
PubMed
- 37 citationsImproved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial.Jason J. Luke, Benjamin E. Onderdonk, S.R. Bhave, Theodore Karrison, Jeffrey Lemons
Clinical Cancer Research. 2020-10-07 - 15 citationsA Validated T Cell Radiomics Score Is Associated With Clinical Outcomes Following Multisite SBRT and Pembrolizumab.Mark Korpics, Mei Yin C. Polley, S.R. Bhave, Gage Redler, Sean P. Pitroda
International Journal of Radiation Oncology, Biology, Physics. 2020-09-01 - 16 citationsEarly prediction of the response of breast tumors to neoadjuvant chemotherapy using quantitative MRI and machine learning.Subramani Mani, Yukun Chen, Lori R. Arlinghaus, Xia Li, A. Bapsi Chakravarthy
AMIA ... Annual Symposium Proceedings. AMIA Symposium. 2011-01-01
Press Mentions
Multidisciplinary Lung ClinicDecember 13th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
